| RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
1423186-80-4 |
| CAIX Inhibitor S4 |
CAIX Inhibitor S4 |
1330061-67-0 |
| 3-(1,3-benzothiazol-5-yl)-7-(1,3-dimethyl-1H-pyrazol-5-yl)thieno[3,2-c]pyridin-4-amine |
GSK-843 |
1601496-05-2 |
| FIT-039 |
FIT-039 |
1113044-49-7 |
| Ribocil |
1381289-58-2 |
1381289-58-2 |
| ML311 |
315698-17-0 |
315698-17-0 |
| CRANAD 28 |
CRANAD 28 |
1623747-97-6 |
| PCNA-I1 |
PCNA-I1 |
444930-42-1 |
| Aldose reductase-IN-1 |
1355612-71-3 |
1355612-71-3 |
| BTT 3033 |
BTT 3033 |
1259028-99-3 |
| CarbaMiMidothioic acid, N,N'-dicyclohexyl-, (5,6-dihydro-6,6-diMethyliMidazo[2,1-b]thiazol-3-yl)Methyl ester, hydrochloride (1:2) |
1092776-63-0 |
1092776-63-0 |
| PI3Kα inhibitor 1 |
PI3Kα 抑制剂1 |
1235449-52-1 |
| Glycine, N-(3,5-dibroMo-4-Methylphenyl)-, 2-[(2-hydroxy-5-nitrophenyl)Methylene]hydrazide |
Glycine, N-(3,5-dibroMo-4-Methylphenyl)-, 2-[(2-hydroxy-5-nitrophenyl)Methylene]hydrazide |
325970-71-6 |
| KL001 |
N-(3-(9H-咔唑-9-基)-2-羟基丙基)-N-(呋喃-2-基甲基)甲烷磺酰胺 |
309928-48-1 |
| IDO-IN-7 |
1402837-78-8 |
1402837-78-8 |
| BAY 299 |
BAY-299 |
2080306-23-4 |
| 4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide |
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide |
36707-00-3 |
| MB-07133 |
VIBEGRON |
1190389-15-1 |
| RO9021 |
CS-2533 |
1446790-62-0 |
| 2-[[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methyl]thio]-N-(2-phenylethyl)acetamide |
CS-2716 |
901751-47-1 |
QQ
微信
